Irbesartan/Hydrochlorothiazide Teva European Union - English - EMA (European Medicines Agency)

irbesartan/hydrochlorothiazide teva

teva b.v.  - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Karvezide European Union - English - EMA (European Medicines Agency)

karvezide

sanofi winthrop industrie - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Rasilez European Union - English - EMA (European Medicines Agency)

rasilez

noden pharma dac - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.

Onduarp European Union - English - EMA (European Medicines Agency)

onduarp

boehringer ingelheim international gmbh - telmisartan - hypertension - cardiovascular system - treatment of essential hypertension in adults:add on therapyonduarp is indicated in adults whose blood pressure is not adequately controlled on amlodipine.replacement therapyadult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of onduarp containing the same component doses.

Riprazo European Union - English - EMA (European Medicines Agency)

riprazo

novartis europharm ltd. - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.

Sprimeo European Union - English - EMA (European Medicines Agency)

sprimeo

novartis europharm ltd. - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.

Tolucombi European Union - English - EMA (European Medicines Agency)

tolucombi

krka, d.d., novo mesto - telmisartan, hydrochlorothiazide - hypertension - telmisartan and diuretics - tolucombi fixed-dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on tolucombi 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.

ALKEM AMLODIPINE amlodipine (as besilate) 10 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alkem amlodipine amlodipine (as besilate) 10 mg tablet bottle

pharmacor pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; silicon dioxide; calcium phosphate; microcrystalline cellulose; sodium starch glycollate type a - hypertension,alkem amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of alkem amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,angina,alkem amlodipine is indicated for the first line treatment of chronic stable angina. alkem amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

ALKEM AMLODIPINE amlodipine (as besilate) 5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alkem amlodipine amlodipine (as besilate) 5 mg tablet bottle

pharmacor pty ltd - amlodipine besilate, quantity: 6.93 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: calcium phosphate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; silicon dioxide - hypertension,alkem amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of alkem amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,angina,alkem amlodipine is indicated for the first line treatment of chronic stable angina. alkem amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

TN-METOPROLOL metoprolol tartrate 100 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tn-metoprolol metoprolol tartrate 100 mg film-coated tablet blister pack

ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; lactose monohydrate; macrogol 400; pregelatinised maize starch; titanium dioxide; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; purified talc; colloidal anhydrous silica - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.